Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma. J Clin Oncol. 2008 Aug 01; 26(22):3743-8.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Biomarkers, Tumor
Carcinoma, Renal Cell
Disease-Free Survival
Drug Administration Schedule
Drug Resistance, Neoplasm
Female
Humans
Indoles
Kidney Neoplasms
Male
Middle Aged
Placenta Growth Factor
Pregnancy Proteins
Prospective Studies
Pyrroles
Time Factors
Treatment Failure
United States
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor C
Vascular Endothelial Growth Factor Receptor-3
authors with profiles
Walter M. Stadler